Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NOD-like Receptor Signaling Pathway in Gastrointestinal Inflammatory Diseases and Cancers. | Int J Mol Sci | 2023 | 37833958 | PubTator, text mining | PubMed |
| Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity. | Cell Death Dis | 2023 | 37833255 | PubTator, text mining | PubMed |
| The Present and Future of Optic Pathway Glioma Therapy. | Cells | 2023 | 37830595 | PubTator, text mining | PubMed |
| Regulating the regulatory T cells as cell therapies in autoimmunity and cancer. | Front Med (Lausanne) | 2023 | 37828948 | PubTator, text mining | PubMed |
| CD70-induced differentiation of proinflammatory Th1/17/22/GM lymphocytes associated with disease progression and immune reconstitution during HIV infection. | Emerg Microbes Infect | 2023 | 37824079 | PubTator, text mining | PubMed |
| Ewing Sarcoma Single-cell Transcriptome Analysis Reveals Functionally Impaired Antigen-presenting Cells. | Cancer Res Commun | 2023 | 37823774 | PubTator, text mining | PubMed |
| Emerging roles of plasmacytoid dendritic cell crosstalk in tumor immunity. | Cancer Biol Med | 2023 | 37817484 | PubTator, text mining | PubMed |
| LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression. | Sci Rep | 2023 | 37813900 | PubTator, text mining | PubMed |
| Immune checkpoints represent a promising breakthrough in targeted therapy and prognosis of myelodysplastic syndrome. | Heliyon | 2023 | 37810157 | PubTator, text mining | PubMed |
| Prognostic and immunological characterization of diffuse large B-cell lymphoma evaluated by co-stimulatory molecular-related features. | Heliyon | 2023 | 37809743 | PubTator, text mining | PubMed |
| Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy. | Front Immunol | 2023 | 37809078 | PubTator, text mining | PubMed |
| [Clinical characteristics and efficacy analysis of 11 patients with primary cutaneous diffuse large B-cell lymphoma, leg type]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37803847 | PubTator, text mining | PubMed |
| Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment. | J Exp Clin Cancer Res | 2023 | 37803464 | PubTator, text mining | PubMed |
| Antibody-drug conjugates: Recent advances in payloads. | Acta Pharm Sin B | 2023 | 37799390 | PubTator, text mining | PubMed |
Interactions of Indoleamine 2,3-dioxygenase-expressing LAMP3+ dendritic cells with CD4+ regulatory T cells and CD8+ exhausted T cells: synergistically remodeling of the immunosuppressive microenvironment in cervical cancer and therapeutic implications. | Cancer Commun (Lond) | 2023 | 37794698 | PubTator, text mining | PubMed |
| Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells. | Cell | 2023 | 37794590 | PubTator, text mining | PubMed |
| Orbital inflammatory pseudotumor: new advances in diagnosis, pathogenesis, and treatment. | Eur J Med Res | 2023 | 37794419 | PubTator, text mining | PubMed |
| Identification of lactate regulation pattern on tumor immune infiltration, therapy response, and DNA methylation in diffuse large B-cell lymphoma. | Front Immunol | 2023 | 37790933 | PubTator, text mining | PubMed |
| Bioconjugated liquid-like solid enhances characterization of solid tumor - chimeric antigen receptor T cell interactions. | Acta Biomater | 2023 | 37788737 | PubTator, text mining | PubMed |
| TSC2 S1365A mutation potently regulates CD8+ T cell function and differentiation and improves adoptive cellular cancer therapy. | JCI Insight | 2023 | 37788104 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=25